JNJ

227.43

+0.07%↑

ISRG

504.37

-3.47%↓

ABT

105.9

-0.72%↓

MDT

100.5

-0.61%↓

A

132.51

-1.42%↓

JNJ

227.43

+0.07%↑

ISRG

504.37

-3.47%↓

ABT

105.9

-0.72%↓

MDT

100.5

-0.61%↓

A

132.51

-1.42%↓

JNJ

227.43

+0.07%↑

ISRG

504.37

-3.47%↓

ABT

105.9

-0.72%↓

MDT

100.5

-0.61%↓

A

132.51

-1.42%↓

JNJ

227.43

+0.07%↑

ISRG

504.37

-3.47%↓

ABT

105.9

-0.72%↓

MDT

100.5

-0.61%↓

A

132.51

-1.42%↓

JNJ

227.43

+0.07%↑

ISRG

504.37

-3.47%↓

ABT

105.9

-0.72%↓

MDT

100.5

-0.61%↓

A

132.51

-1.42%↓

Search

Evolent Health Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

3.23 -3.87

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.16

Max

3.37

Pagrindiniai rodikliai

By Trading Economics

Pajamos

30M

-21M

Pardavimai

35M

480M

Pelno marža

-4.351

Darbuotojai

4,500

EBITDA

512K

15M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+174.41% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-02-19

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-349M

430M

Ankstesnė atidarymo kaina

7.1

Ankstesnė uždarymo kaina

3.23

Naujienos nuotaikos

By Acuity

50%

50%

133 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

Evolent Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-28 23:51; UTC

Uždarbis

Correction to Samsung Fourth-Quarter Net Profit Article

2026-01-28 23:49; UTC

Karštos akcijos

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

2026-01-28 23:19; UTC

Uždarbis

Samsung's Fourth-Quarter Net Profit Beats Consensus

2026-01-28 22:43; UTC

Uždarbis

Waste Management Logs Higher 4Q Profit as Revenue Rises

2026-01-29 00:00; UTC

Įsigijimai, susijungimai, perėmimai

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

2026-01-29 00:00; UTC

Įsigijimai, susijungimai, perėmimai

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

2026-01-29 00:00; UTC

Įsigijimai, susijungimai, perėmimai

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

2026-01-29 00:00; UTC

Įsigijimai, susijungimai, perėmimai

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

2026-01-28 23:49; UTC

Rinkos pokalbiai

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

2026-01-28 23:30; UTC

Rinkos pokalbiai

Tesla to Use Car Factory for Robot Aims -- Market Talk

2026-01-28 23:28; UTC

Uždarbis

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

2026-01-28 23:26; UTC

Uždarbis

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

2026-01-28 23:21; UTC

Uždarbis

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

2026-01-28 23:18; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

2026-01-28 22:58; UTC

Uždarbis

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

2026-01-28 22:48; UTC

Rinkos pokalbiai

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

2026-01-28 22:45; UTC

Uždarbis

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

2026-01-28 22:44; UTC

Uždarbis

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

2026-01-28 22:43; UTC

Uždarbis

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

2026-01-28 22:41; UTC

Uždarbis
Karštos akcijos

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

2026-01-28 22:41; UTC

Rinkos pokalbiai

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

2026-01-28 22:41; UTC

Uždarbis

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

2026-01-28 22:40; UTC

Uždarbis

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

2026-01-28 22:39; UTC

Uždarbis

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

2026-01-28 22:38; UTC

Uždarbis

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

2026-01-28 22:37; UTC

Uždarbis

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

2026-01-28 22:35; UTC

Uždarbis

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

2026-01-28 22:26; UTC

Rinkos pokalbiai
Uždarbis

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

2026-01-28 22:20; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-28 22:20; UTC

Rinkos pokalbiai

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Akcijų palyginimas

Kainos pokytis

Evolent Health Inc Prognozė

Kainos tikslas

By TipRanks

174.41% į viršų

12 mėnesių prognozė

Vidutinis 9.33 USD  174.41%

Aukščiausias 16 USD

Žemiausias 5 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Evolent Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

14 ratings

13

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

10.33 / 10.95Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

133 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat